Background: The ability to identify low-level somatic DNA mutations and minority alleles within an excess wild-type sample is becoming essential for characterizing early and …
T Lecomte, A Berger, F Zinzindohoué… - … journal of cancer, 2002 - Wiley Online Library
Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor …
Abstract O 6-Methylguanine DNA methyltransferase (MGMT) is a DNA repair protein that removes mutagenic and cytotoxic adducts from the O 6 position of guanine. O 6 …
N Kokudo, Y Miki, S Sugai, A Yanagisawa… - Archives of …, 2002 - jamanetwork.com
Hypothesis There have been few reports on the minimum surgical margins (SMs) required for successful liver resection in patients with colorectal metastases. This minimum …
I Bentwich - US Patent 7,250,496, 2007 - Google Patents
The present invention relates to a first group of novel genes, here identified as “genomic address messenger” or “GAM” genes, and a second group of novel operon-like genes, here …
V Plagnol, S Woodhouse, K Howarth, S Lensing… - PloS one, 2018 - journals.plos.org
Circulating tumor DNA (ctDNA) analysis is being incorporated into cancer care; notably in profiling patients to guide treatment decisions. Responses to targeted therapies have been …
SN Lapidus, AP Shuber - US Patent 5,928,870, 1999 - Google Patents
This invention relates to methods useful for disease diagnosis by detecting loss of heterozygosity in cellular samples containing a small amount of mutated genetic material …
T Yamada, S Nakamori, H Ohzato, S Oshima… - Clinical cancer research …, 1998 - AACR
We investigated the presence of K-ras gene mutation in plasma DNA and assessed its clinical value in patients with pancreatic adenocarcinoma. Mutations in codon 12 of the K …